David G Ward

Title: David G Ward: Innovator in Cardiovascular Therapy

Introduction

David G Ward is a notable inventor based in Oakdale, CA (US). He has made significant contributions to the field of cardiovascular therapy, particularly through his innovative use of relaxin in medical treatments. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from heart-related conditions.

Latest Patents

Ward's latest patents include groundbreaking inventions focused on the use of relaxin. The first patent addresses the use of relaxin in the treatment of bradycardia. This invention concerns the application of relaxin or other compounds that can specifically bind to a relaxin receptor in the heart, aimed at treating acute and chronic heart failure, as well as conditions characterized by pathologically low heart rates. The second patent expands on this concept, detailing the use of relaxin in cardiovascular therapy, specifically targeting acute and chronic heart failure.

Career Highlights

David G Ward is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to explore and develop new therapeutic strategies that leverage the unique properties of relaxin.

Collaborations

Throughout his career, Ward has collaborated with esteemed colleagues, including Michael J Cronin and Phyllis L Osheroff. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

David G Ward's contributions to the field of cardiovascular therapy through his innovative use of relaxin highlight his role as a significant inventor. His patents not only showcase his expertise but also hold promise for improving patient outcomes in heart-related conditions.